Home LiteratureArticle Details
PMID: 12711323 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

SEK1-dependent JNK1 activation prolongs cell survival during G-Rh2-induced apoptosis.

Biochemical and biophysical research communications ·Vol. 304 ·No. 2 ·2003-05-02 ·Pages 358-64

Ham YM, Chun KH, Choi JS, Kim DH, Lee SK

Abstract

We provide here evidence that c-Jun N-terminal protein kinase 1 (JNK1) activity is differentially up-regulated during apoptosis of SK-HEP-1 cells after treatment with ginsenoside Rh2 (G-Rh2). The G-Rh2-mediated JNK1 activation that occurred for the first 10-30min was associated with SEK1 activity, but thereafter, the sustained activation was associated not with SEK1 activity, but with proteolytic cleavage of JNK1-associated p21(WAF1/CIP1). Supporting this is that the expression of the dominant negative SEK1 mutant effectively blocked the early JNK1 activation phase but did not alter the sustained activation phase or apoptosis. Furthermore, expression of p21D112N, an uncleavable mutant of p21(WAF1/CIP1), suppressed the later JNK1 activation. Moreover, the stable overexpression of ectopic JNK1 suppressed apoptosis while expression of the dominant negative JNK1 mutant promoted it. We propose that the early SEK1-associated JNK1 activation phase acts to prolong cell survival in response to apoptosis-inducing agents, thereby serving as an intervening checkpoint prior to the commitment to apoptosis.

MeSH Terms
Apoptosis Cell Survival Cyclin-Dependent Kinase Inhibitor p21 Cyclins/metabolism Enzyme Activation Ginsenosides/pharmacology Humans Kinetics MAP Kinase Kinase 4 MAP Kinase Signaling System Mitogen-Activated Protein Kinase 8 Mitogen-Activated Protein Kinase Kinases/metabolism,physiology Mitogen-Activated Protein Kinases/genetics,metabolism,physiology Mutation Tumor Cells, Cultured
Chemicals
CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 Cyclins Ginsenosides ginsenoside Rh2 Mitogen-Activated Protein Kinase 8 Mitogen-Activated Protein Kinases MAP Kinase Kinase 4 MAP2K4 protein, human Mitogen-Activated Protein Kinase Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Ham Young-Mi
Division of Pharmaceutical Biosciences, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Seoul National University, San 56-1, Shillim-Dong, Kwanak-Gu, 151-742, Seoul, Republic of Korea.
Chun Kwang-Hoon
Choi Joon-Seok
Kim Dong-Hyun
Lee Seung-Ki
Article Info
Journal
Biochemical and biophysical research communications
Abbr.
Biochem Biophys Res Commun
ISSN
0006-291X
Published
2003-05-02
Pages
358-64
Language
English
Region
United States
NLM ID
0372516
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com